Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).
Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India.
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.
Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Combined effects of transferrin and thyroid hormone during oligodendrogenesis In vitro.
The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?
Ultrastructural pathology of human peritumoural oedematous cerebellar cortex.
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.
Ultrastructural, ssrDNA sequencing of Myxobolus prochilodus and Myxobolus porofilus and details of the interaction with the host Prochilodus lineatus.
Automated multi-objective calibration of biological agent-based simulations.
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
Optic Neuritis in a Patient with Bickerstaff's Brainstem Encephalitis.
Cognitive motor interference in multiple sclerosis: Insights from a systematic, quantitative review.
Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Pathology and MRI: exploring cognitive impairment in MS.
Progressive Multifocal Leucoencephalopathy and psoriasis.
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Virtual street-crossing performance in persons with multiple sclerosis: Feasibility and task performance characteristics.
Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site.
Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin.
Diffusion tensor microscopy data (15.6 μm in-plane) of white matter tracts in the human, pig, and rat spinal cord with corresponding tissue histology.
Pages
« first
‹ previous
…
824
825
826
827
828
829
830
831
832
…
next ›
last »